NTRA News

Sequoia Capital the is the largest shareholder of Chinese credit platform Jianpu Technology (JT), which begins trading on the NYSE on Thursday. The big kahuna of Silicon Valley has been the #1 investor of 6 US IPOs since 2015. While its three IPOs from 2015 to 2016...read more

AutoGenomics, which sells a molecular diagnostics system for genetic testing in clinical laboratories, withdrew its plans for an initial public offering on Monday. It had first filed to go public in 2008 but withdrew its plans in 2011. It then set terms in February 2013 but withdrew the offering later that year. In February 2015, AutoGenomics planned to raise $45 million at a...read more

Natera, which sells non-invasive prenatal disease screening tests, raised $180 million by offering 10.0 million shares at $18, the high end of the range of $17 to $18. Natera previously filed to raise $100 million by offering 6.3 million shares at $15-$17. Natera plans to list on the NASDAQ under the symbol NTRA. Natera initially filed confidentially on 5/14/2014. Morgan Stanley,...read more

Natera, which sells non-invasive prenatal disease screening tests, raised the proposed deal size for its upcoming IPO on Wednesday. The San Carlos, CA-based company now plans to raise $175 million by offering 10 million shares at a price range of $17 to $18. The company had previously filed to offer 6 million shares at a range of $15 to $17. At the midpoint of the revised range,...read more